Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,219 | Dovepress* | 11,067+ | 1,464 | 12,531 | |
| PubMed Central* | 1,152 | 328 | 1,480 | ||
| Totals | 12,219 | 1,792 | 14,011 | ||
| *Since 22 July 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 9 | 0 | 0 | 0 | 1 | 8 |
View citations on PubMed Central and Google Scholar